Monteris Medical
Monteris Medical specializes in the NeuroBlate® System, a minimally invasive, robotically controlled laser thermotherapy for ablating brain lesions, tumors, and drug-resistant epilepsy.
NeuroBlate® System
The NeuroBlate® System by Monteris Medical is a minimally invasive, robotically controlled laser thermotherapy device. It uses MRI-guided laser light to ablate brain lesions or unwanted tissue. The system is unique in being the only robotic MR-guided laser ablation tool available for treating brain tumors, radiation necrosis, and drug-resistant epilepsy. The system includes various components such as disposables, hardware, Fusion™ Software, and TruTemp™ Technology.
Robotic and Laser Technology
The NeuroBlate System's robotic probe driver offers precise robotic linear positioning and hands-off laser manipulation, allowing for either single trajectories or multiple, sequential trajectories with one probe. The system's FullFire 1.6mm Laser Probe is the smallest commercially available laser probe for brain use. Additionally, the NeuroBlate Optic™ Laser Probe is notable for being the first and only laser probe with fiber optic controlled cooling, ensuring optimal performance and safety.
TruTemp™ Technology
Monteris Medical integrates TruTemp™ Technology into the NeuroBlate System to enhance the accuracy of MRI thermometry. This technology mitigates factors that negatively influence the measurement, providing greater confidence in the accuracy of the ablation zone. TruTemp™ ensures that deeper penetration of laser energy occurs with a measured and steady rate of heating for controlled tissue ablation.
Fusion™ Software
The NeuroBlate Fusion-S™ Software provides the necessary visualization, control, and efficiency required to make critical decisions during brain tissue laser ablation procedures. It allows for accurately fusing preoperative Diffusion Tensor Imaging (DTI) data with day-of-treatment images, leading to more precise and effective treatments.
Clinical Studies and Outcomes
Monteris Medical has been proactive in sponsoring the collection of data on the acute and long-term outcomes of the NeuroBlate System through eight clinical studies. Notably, the LAANTERN study is the largest laser ablation registry for the brain, enrolling over 1,000 patients in the United States and Canada. This study has been instrumental in assessing the system's effectiveness and long-term benefits.